PT1284993E - Polipéptidos contendo polimorfismos das regiões repetidas de pertactina em bordetella pertussis, bordetella parapertussis e bordetella bronchiseptica, sua utilização em diagnóstico e em composições imunogénicas - Google Patents

Polipéptidos contendo polimorfismos das regiões repetidas de pertactina em bordetella pertussis, bordetella parapertussis e bordetella bronchiseptica, sua utilização em diagnóstico e em composições imunogénicas Download PDF

Info

Publication number
PT1284993E
PT1284993E PT01945261T PT01945261T PT1284993E PT 1284993 E PT1284993 E PT 1284993E PT 01945261 T PT01945261 T PT 01945261T PT 01945261 T PT01945261 T PT 01945261T PT 1284993 E PT1284993 E PT 1284993E
Authority
PT
Portugal
Prior art keywords
bordetella
pertactin
bronchiseptica
repeated regions
pertussis
Prior art date
Application number
PT01945261T
Other languages
English (en)
Portuguese (pt)
Inventor
Nicole Guiso-Maclouf
Caroline Boursaux-Eude
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Publication of PT1284993E publication Critical patent/PT1284993E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PT01945261T 2000-05-25 2001-05-23 Polipéptidos contendo polimorfismos das regiões repetidas de pertactina em bordetella pertussis, bordetella parapertussis e bordetella bronchiseptica, sua utilização em diagnóstico e em composições imunogénicas PT1284993E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20696900P 2000-05-25 2000-05-25

Publications (1)

Publication Number Publication Date
PT1284993E true PT1284993E (pt) 2008-06-11

Family

ID=22768696

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01945261T PT1284993E (pt) 2000-05-25 2001-05-23 Polipéptidos contendo polimorfismos das regiões repetidas de pertactina em bordetella pertussis, bordetella parapertussis e bordetella bronchiseptica, sua utilização em diagnóstico e em composições imunogénicas

Country Status (11)

Country Link
US (3) US7070779B2 (enExample)
EP (1) EP1284993B1 (enExample)
JP (1) JP2003533990A (enExample)
AT (1) ATE393166T1 (enExample)
AU (1) AU2001267527A1 (enExample)
CY (1) CY1110430T1 (enExample)
DE (1) DE60133734T2 (enExample)
DK (1) DK1284993T3 (enExample)
ES (1) ES2303833T3 (enExample)
PT (1) PT1284993E (enExample)
WO (1) WO2001090143A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2646776B1 (fr) * 1989-05-12 1994-06-03 Pasteur Institut Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
ATE393166T1 (de) 2000-05-25 2008-05-15 Pasteur Institut Polypeptide die polymorphismen aus bordertella pertussis, bordetella parapertussis und bordetella bronchiseptica pertactin wiederholende regionen enthalten, ihre verwendung in diagnostik und immunogene zusammensetzungen
US8465754B2 (en) 2007-05-28 2013-06-18 Kitasato Daiichi Sankyo Vaccine Co., Ltd. Bordetella parapertussis whole-cell vaccine composition
CU23679A1 (es) 2007-10-30 2011-07-11 Ct Ingenieria Genetica Biotech Variantes de pertactinas para uso vacunal
WO2010131111A1 (en) * 2009-05-11 2010-11-18 Novartis Ag Antigen purification process for pertactin antigen
US8261986B2 (en) * 2009-10-21 2012-09-11 Kevin Kwong-Tai Chung System and method for decoding an optically readable markable sheet and markable sheet therefor
WO2012104820A1 (en) * 2011-02-04 2012-08-09 Pfizer Inc. Compositions for canine respiratory disease complex
JP5833145B2 (ja) * 2011-02-04 2015-12-16 ゾエティス・エルエルシー 免疫原性bordetellabronchiseptica組成物
CN109879942A (zh) * 2019-03-01 2019-06-14 浙江省农业科学院 一种兔波氏杆菌外膜蛋白及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9007416D0 (en) * 1990-04-02 1990-05-30 Wellcome Found Expression of heterologous protein in yeast
GB9027901D0 (en) * 1990-12-21 1991-02-13 Wellcome Found Acellular vaccine
FR2728170A1 (fr) * 1994-12-15 1996-06-21 Pasteur Institut Vaccin de type acellulaire anti-bordetella
ATE393166T1 (de) 2000-05-25 2008-05-15 Pasteur Institut Polypeptide die polymorphismen aus bordertella pertussis, bordetella parapertussis und bordetella bronchiseptica pertactin wiederholende regionen enthalten, ihre verwendung in diagnostik und immunogene zusammensetzungen

Also Published As

Publication number Publication date
DE60133734D1 (de) 2008-06-05
DE60133734T2 (de) 2009-05-14
US20030180307A1 (en) 2003-09-25
US6964767B2 (en) 2005-11-15
US7070779B2 (en) 2006-07-04
CY1110430T1 (el) 2012-05-23
WO2001090143A3 (en) 2002-09-26
DK1284993T3 (da) 2008-07-28
US20060008474A1 (en) 2006-01-12
ES2303833T3 (es) 2008-09-01
EP1284993A2 (en) 2003-02-26
JP2003533990A (ja) 2003-11-18
EP1284993B1 (en) 2008-04-23
AU2001267527A1 (en) 2001-12-03
US20020192237A1 (en) 2002-12-19
US20040166116A9 (en) 2004-08-26
ATE393166T1 (de) 2008-05-15
WO2001090143A2 (en) 2001-11-29
US7314910B2 (en) 2008-01-01

Similar Documents

Publication Publication Date Title
CY1110430T1 (el) Πολυπεπτιδια περιεχοντα πολυμορφισμους των επαναλαμβανομενων περιοχων της περτακτινης σε bordetella pertussis, bordetella paraperussis kai bordetella bronchiseptica. χρηση αυτων σε διαγνωστικες και ανοσογονες συνθεσεις
MXPA02010826A (es) Compuestos y metodos para el tratamiento y la prevencion de infeccion bacteriana.
MXPA04004106A (es) Composiciones cosmeticas anhidras que contienen polioles.
ATE263157T1 (de) Nematizide trifluorbutene
GEP20094675B (en) Heteroaryl- tetra-hydropiperidyl compounds useful for treating or preventing pain
MXPA03000612A (es) Metodos y procesos mejorados para desinfeccion con yodo.
BR0108058A (pt) Corpo maciço
SG123755A1 (en) Surface-modified silicon dioxide-titanium dioxide mixed oxides
DE50204688D1 (de) N-alkylaziridinoprepolymere als dentalmasse
EP1395283A4 (en) HETEROLOGICAL PROTECTION, INDUCED BY IMMUNIZATION WITH THE INVAPLEX VACCINE
AU6720601A (en) Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof
WO2001074394A8 (en) New combination of a betablocker and a cholesterol-lowering agent
AP2049A (en) Medicament containing activated antithrombin III
DE60120120D1 (de) Beutelformzusammensetzungen
EP1303300A4 (en) COMPOSITIONS AND METHODS FOR TREATING CANDIDIASIS
LU90378I2 (fr) Tetravac
MXPA02012015A (es) Ligandos de receptores para integrinas.
ATE443755T1 (de) Erkennung, vorbeugung und behandlung papillomatöser digitaler dermatitis
NZ514027A (en) Cloning and expression of haemophilus somnus transferrin-binding proteins
BR0016616A (pt) Microrganismos atenuados para o tratamento de infecção
Chapman et al. Silence at Ramscliffe
NO20021429D0 (no) 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner
EP1591123A4 (en) USE OF NARINGENINE, NARINGIN AND THEIR SALTS AS EXPERTS IN THE TREATMENT OF COUGH AND COMPOSITIONS THEREOF
Goodhew Cornucopia of delights for materials teaching
DK1149901T3 (da) Mutanter af pestivirus og vacciner indeholdende disse